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Abstract
Calcium has a pivotal role in biological functions, and serum calcium levels have been associated with numerous disorders
of bone and mineral metabolism, as well as with cardiovascular mortality. Here we report results from a genome-wide
association study of serum calcium, integrating data from four independent cohorts including a total of 12,865 individuals
of European and Indian Asian descent. Our meta-analysis shows that serum calcium is associated with SNPs in or near the
calcium-sensing receptor (CASR) gene on 3q13. The top hit with a p-value of 6.3610-37 is rs1801725, a missense variant,
explaining 1.26% of the variance in serum calcium. This SNP had the strongest association in individuals of European
descent, while for individuals of Indian Asian descent the top hit was rs17251221 (p = 1.1610-21), a SNP in strong linkage
disequilibrium with rs1801725. The strongest locus in CASR was shown to replicate in an independent Icelandic cohort of
4,126 individuals (p = 1.02610-4). This genome-wide meta-analysis shows that common CASR variants modulate serum
calcium levels in the adult general population, which confirms previous results in some candidate gene studies of the CASR
locus. This study highlights the key role of CASR in calcium regulation.
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Introduction
Calcium is the most abundant mineral in the human body
contributing approximately one kilogram to the average adult
human body mass. Whereas 99% of calcium is stored in the
skeleton and teeth, the remaining 1% circulates in the bloodstream
and is involved in many physiological processes including its
function as a universal cellular signaling molecule [1–2]. Calcium
plays a key role in membrane potential, which is important for
muscle contraction, heart rate regulation and generation of nerve
impulses. Calcium also influences bone metabolism, ion transport
and many other cellular processes [3]. Approximately 2/5 of
calcium in the extracellular fluid is found in blood serum. The
level of serum calcium is under tight hormonal control with a
normal concentration of 2.15–2.55 mmol/L. Serum calcium is
under strong genetic control, with twin studies showing that the
variance in total calcium due to genetic effects is between 50% and
78% [4–5].
While skeletal calcium is important in numerous clinical
disorders, in particular bone and mineral disorders, the clinical
role of serum calcium is less clear. Several [6–7] (but not all [8])
studies indicated that elevated serum calcium levels are associated
with an increased risk of cardiovascular disease. Patients with
hyperparathyroidism, who suffer from chronic hypercalcemia,
have a high prevalence of hypertension and increased cardiovas-
cular mortality [9–11]. However, the mechanisms underlying the
putative association of serum calcium with increased cardiovascu-
lar morbidity and mortality remain unclear.
Rare monogenic forms of hypo- or hypercalcemia have been
described, including disorders involving the calcium-sensing
receptor (CASR, locus 3q13) gene. Heterozygous and homozy-
gous CASR mutations that inactivate CASR are responsible,
respectively, for familial hypocalciuric hypercalcemia, type 1
(also known as familial benign hypercalcemia) (OMIM
#145980) [12–13] and neonatal severe hyperparathyroidism
(OMIM #239200) [13]. On the other hand, mutations that
result in CASR activation lead to autosomal dominant
hypocalcemia (OMIM #146200) [14]. Mutations in many
other genes have also been found to lead to disturbances of
serum calcium levels (Table 1).
In the present study, we report results obtained from meta-
analysis of genome-wide associations of serum calcium levels from
four cohorts with a total of 12,865 participants. We first describe
the design of the study and its main finding, that variants in CASR
give rise to the strongest signals associated with serum calcium
levels in both European and Indian Asian populations. Our results
confirm previous studies showing that mutations in CASR
are associated with serum calcium levels in young healthy women
[15–16] and extend this observation to men and women across a
large spectrum of age. We show that CASR is a key player in the
genetic regulation of serum calcium in men and women from the
general adult population.
Results
We performed a meta-analysis for genome-wide associations of
serum calcium, determined by subtracting the estimated amount
of calcium bound to albumin from the total serum calcium, to infer
the amount of ionized calcium (see Materials and Methods). Our
study included four cohorts: (i) 5404 European individuals from
the Cohorte Lausanne (CoLaus) [17–18], (ii) 5548 European and
Indian Asian individuals from the London Life Sciences
Population (LOLIPOP) Study from West London UK [19–20],
(iii) 1196 European individuals from the InCHIANTI Study
(Tuscany, Italy) [21], and (iv) 717 individuals of European descent
from the Baltimore Longitudinal Study of Aging (BLSA) study
based in the Baltimore-Washington DC area [22], totaling 12,865
participants (see Table 2 for more detailed characteristics of each
cohort).
Genome-wide association scans were performed first indepen-
dently for each cohort using linear regression and then the effect
sizes from each cohort were meta-analyzed (see Materials and
Methods). Due to the possibility of population substructure
obscuring effects of genetic variants, meta-analysis was performed
separately for (i) combined European and Indian Asian cohorts
(N= 12,865) and restricted to cohorts of (ii) European
(N= 8,919), and (iii) Indian Asian descent (N= 3,947). The
meta-analyses yielded 100 SNPs from the combined cohorts, 70
SNPs when restricting to European cohorts and 22 SNPs
restricting to Indian Asian cohorts that exceeded the genome-
wide significance threshold of 5610-8 (Figure 1A–1C) (the full list
is provided in Table S2A, S2B, S2C). All SNPs reaching statistical
significance clustered around the CASR locus at 3q13. The most
significant SNP in the (i) combined and (ii) European meta-
analyses was rs1801725 (p = 6.29610-37, p = 2.58610-18, respec-
tively) and in the (iii) Indian Asian meta-analysis was rs17251221
(p = 1.07610-21). These two SNPs are less than 11 kb apart and
are in high linkage disequilibrium with each other (r2 = 0.946,
0.494, 1.0, 1.0 in HapMap CEU, CHB, JPT, YRI, respectively),
and therefore most likely derive from the same association signal.
We find that rs1801725 explains 1.26% of the variance in serum
calcium, with the effect sizes and standard errors of the serum
calcium increasing T allele in individual cohorts shown in Figure 2
and Table S3. According to our additive model, each rs1801725
T allele increases log10 serum calcium (in units mmol/L) by
3.61610-3, equivalent to a multiplicative effect of 1.008 on serum
calcium (see also Table S2). At an average serum calcium level of
2.25 mmol/L, each rs1801725 T allele yields an increase of
0.01874 mmol/L, or 21% of one standard deviation of serum
calcium levels in a normal population. The regional pattern of
association of SNPs around the CASR locus, and their linkage
disequilibrium with rs1801725, are shown in Figure 3. Of note,
rs1042636, which has been associated with decreased serum
calcium [23], also achieved genome-wide significance with the G
minor allele associated with decreased serum calcuim
(p= 4.96610-9). However, conditional on the rs1801725 locus,
located 12 bps upstream, the rs1042636 p-value became
3.3261024, indicating that the two loci share contributions to
serum calcium levels.
To confirm the rs1801725 signal, we analyzed the association
pattern with serum calcium in a separate cohort. We used a
subset of 4,126 Icelandic individuals from the deCODE study
[24–25] with serum calcium measurements. We found the
rs1801725 T allele to be strongly associated with increased
serum calcium (p= 1.02610-4), replicating the key meta-analysis
result.
While only the CASR locus reached nominal genome-wide
significance for association with serum calcium, the top regions
with p,10-5 are shown in Table 3. These SNPs cover 12 regions,
the significance of which is displayed across cohorts in Figure S3.
There were no SNPs in other candidate genes (which have
previously been shown to be involved in disorders associated with
disturbed serum calcium levels) that were associated with serum
calcium at genome-wide significance. The most significant SNPs
within 500 kb of the gene transcripts are shown in Table 1.
Considering the set of 18,611 distinct SNPs mapping to the set of
serum calcium candidate genes excluding CASR, we find no
significant association (at significance level 0.05 and applying the
Serum Calcium Meta-Analysis
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Bonferroni correction for multiple testing, giving a cut-off p-value
of 2.69610-6, see also Figure S4). Indeed, fixing the sample size
and genome-wide significance threshold our study is well-powered
($0.80) to detect SNPs explaining at least 0.31% of the variance.
Therefore the common SNPs within the candidate genes
(excluding CASR) likely play at best a small role in serum calcium
regulation.
We analyzed the association of the top SNP with several
calcium-related outcomes (coronary heart disease, myocardial
infarction, hypertension, stroke, osteoarthritis, osteoporosis and
kidney stones). The number of cases and controls for each
outcome and each cohort is given in Table S4. Logistic regression
including age and pseudosex (see Materials and Methods) as
covariates did not find any significant association between
rs1801725 and the calcium-related outcomes, after correcting for
multiple testing (effect sizes and standard errors for the T allele are
listed in Table S5). Power calculations show that given the sample
sizes for the clinical traits above, our study has good power ($0.80)
to detect odds ratios of 1.20, 1.13, 1.77, 1.27, 1.27, 1.24 and 1.75,
respectively. As the smallest p-values from calcium-related traits
were for osteoarthritis and osteoporosis (bonferroni-corrected
p= 0.21, 0.44, respectively), we further investigated bone density
traits. None of deCODE hip bone mineral density or spine bone
mineral density (N= 6657 and 6838, respectively) nor In-
CHIANTI total bone density, trabecular bone density, cortical
bone density, cortical bone thickness or cortical bone area
(N= 1196) bonferroni-adjusted p-values for eight traits were
significant.
Discussion
This genome-wide scan of 12,865 individuals revealed CASR as
the most significant (and only genome-wide significant) locus
influencing serum calcium levels. Specifically, we found evidence
for a strong association of SNPs located in the CASR locus with
serum calcium levels in both Europeans and Indian Asians. The
strongest locus in CASR was further shown to replicate in an
independent Icelandic cohort of 4,126 individuals.
The top signal (rs1801725, 2956G.T) explains 1.26% of the
variance in serum calcium. Indeed, this is similar to results from
other GWAS of human height [26–29], body mass index [30–31],
serum urate [32–34] and serum lipid concentrations [34–36], for
which the genome-wide significant loci uncovered thus far
collectively explain only a small fraction of the phenotypic
variance (usually at least one order of magnitude less than the
total additive genetic variance estimated from heritability studies
[37–38]). The rs1801725 T allele (A986S) was associated with
higher serum calcium, consistent with previous findings (see Table
S6). The rs1801725 polymorphism (with T allele frequencies of
16.76%, 19.98% in European and Indian Asian cohorts,
respectively) affects serum calcium levels of a substantial
proportion of the population.
The rs1801725 polymorphism encodes a missense variant in
exon 7 of the CASR gene, which leads to a non-conservative
amino-acid change (serine substitution for alanine-986, A986S
corresponding to nucleotides 2956G.T) in the cytoplasmic tail of
CASR. In vitro studies showed that mutations within the C-
terminal tail may influence several aspects of CASR function,
such as signal transduction, intracellular trafficking and cell
surface expression [39–41]. However, PolyPhen predicts
rs1801725 to be a benign substitution. It is presently unclear
whether this substitution gives rise to functional variants, as
functional studies have yielded conflicting results [42–43]. Deep
sequencing of this region may help identifying the causal variants.
While it is still not possible to infer a direct causal role, it is of
interest to note that the SNP gives rise to an amino acid change
in the C-terminal tail of CASR, a domain which plays a key role
in the receptor function and may potentially influence intracel-
lular trafficking following CASR activation by extracellular
calcium.
Several studies have reported associations of A986S and
nearby CASR mutations with various phenotypes. The A986S
CASR polymorphism has been associated with variations in
circulating calcium levels in healthy adults in some studies
[15,23,44–45], but not in others [46–47]. The fact that the latter
studies were underpowered (sample size ranging from 148 to
1252) to detect a small effect size likely explains these inconsistent
results. The rs1042636 (R990G) polymorphism has been
associated with the magnitude of parathyroid hormone (PTH)
secretion in patients with primary hyperparathyroidism [48], and
preliminary results suggest that it could influence response to
cinacalcet, a calcimimetic used to treat secondary hyperparathy-
roidism in patients with end-stage renal disease [49]. In a meta-
analysis, 986S was associated with a 49% increased risk
(P = 0.002) of primary hyperparathyroidism [47,50–51]. Among
patients with primary hyperparathyroidism, the AGQ haplotype
(i.e. 986A, 990G, 1011Q, which is associated with lower serum
calcium levels and hypercalciuria [52]) was associated with
increased risk, and the SRQ haplotype with decreased risk, of
kidney stones [50].
CASR has been previously considered as a candidate gene for
osteoporosis [53] and coronary heart disease as well as increased
total and cardiovascular mortality [54]. In our meta-analysis, we
found no significant association of rs1801725 with these calcium-
related phenotypes. A recent meta-analysis focusing on effects of
candidate genes on osteoporosis also reports negative results for
CASR [55]. Furthermore, results on the association of elevated
serum calcium with increased cardiovascular risk in the general
population are controversial [6–8]. It is therefore not clear to
what extent serum calcium might predict cardiovascular risk. The
SNPs identified in this meta-analysis could serve as genetic
instruments in future studies, such as Mendelian randomization
analysis in longitudinal cohorts, to further investigate the causal
effect of serum calcium on osteoporosis and on cardiovascular
disease risk (see Table S5 for rs1801725 effects and standard
errors).
Our meta-analysis suffers from some limitations. First, we used
corrected serum calcium and not directly measured ionized serum
calcium. The correlation between corrected serum calcium and
Author Summary
Calcium levels in blood serum play an important role in
many biological processes. The regulation of serum
calcium is under strong genetic control. This study
describes the first meta-analysis of a genome-wide
association study from four cohorts totaling 12,865
participants of European and Indian Asian descent.
Confirming previous results in some candidate gene
studies, we find that common polymorphisms at the
calcium-sensing receptor (CASR) gene locus are associated
with serum calcium concentrations. We show that CASR
variants give rise to the strongest signals associated with
serum calcium levels in both European and Indian Asian
populations, while no other locus reaches genome-wide
significance. Our results show that CASR is a key player in
genetic regulation of serum calcium in the adult general
population.
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ionized serum calcium varies between 0.66 and 0.87 [56–58]. We
can hypothesize that the association of ionized serum calcium with
CASR variants would be stronger than the one with corrected
serum calcium because ionized calcium is the form physiologically
active on CASR. Second, data on serum phosphate, PTH or
vitamin D are not available, so that we cannot explore further
these relationships. Third, sample sizes for calcium-related clinical
traits were limited, many clinical traits in CoLaus were self-
reported instead of clinically diagnosed, and we incur a multiple
testing penalty due to the number of clinical traits posited to be
associated with serum calcium. However, the major strengths of
the study are the hypothesis-free nature of GWAS studies, the
large sample meta-analysis and the inclusion of multiple
populations.
Materials and Methods
Cohorts
CoLaus is a population-based sample from Lausanne,
Switzerland, consisting of 5435 individuals between 35 and 75
years old (after QC) of which a subset of 5404 had available
serum calcium measurements. The study design and protocols
have been described previously [17–18]. The CoLaus study was
approved by the Institutional Ethic’s Committee of the University
of Lausanne. The London Life Sciences Prospective Population
Study (LOLIPOP) is an ongoing population-based cohort study
of ,30,000 Indian Asian and European white men and women,
aged 35–75 years living in West London, United Kingdom [59].
All study participants gave written consent including for genetic
studies. The LOLIPOP study is approved by the local Research
Ethics Committee. The participants included in the present study
are a subset of 3947 Indian Asians and 1601 Europeans from the
LOLIPOP cohort study. LOLIPOP individuals are separated by
origin as well as the genotyping platform, with IAA, IAI or IAP
denoting Indian Asians genotyped on Affymetrix, Illumina or
Perlegen platforms, respectively, and EWA and EWI denoting
Europeans genotyped on Affymetrix or Illumina platforms,
respectively (see Table S1). The InCHIANTI study is a
population-based epidemiological study aimed at evaluating the
factors that influence mobility in the older population living in
the Chianti region in Tuscany, Italy. The details of the study have
been previously reported [60]. Overnight fasted blood samples
were taken for genomic DNA extraction, and measurement of
serum calcium. For this study, 1196 subjects with serum calcium
and GWAS data were analyzed. The study protocol was
approved by the Italian National Institute of Research and Care
of Aging Institutional Review and Medstar Research Institute
(Baltimore, MD). The Baltimore longitudinal study on Aging
(BLSA) study is a population-based study aimed to evaluate
contributors of healthy aging in the older population residing
predominantly in the Baltimore-Washington DC area [61].
Starting in 1958, participants are examined every one to four
years depending on their age. Blood samples were collected for
DNA extraction. This analysis focused on a subset of the
participants (N= 717) of European ancestry. The BLSA has
continuing approval from the Institutional Review Board (IRB) of
Medstar Research Institute. Approval was obtained from local
ethic committees for all studies and all participants signed
informed written consent. The deCODE study consists of
individuals who visited a private outpatient laboratory, the
Laboratory in Mjodd, Reykjavik, Iceland between 1997 and
2008. The main referral center for this laboratory is a
multispecialty medical clinic in Reykjavik (Laeknasetrid). For
the serum calcium analysis we used information on 4,126
individuals with both genome-wide SNP data and measured
serum calcium and serum albumin. The samples for bone density
analysis have previously been described in detail [24–25]. For this
study 6,657 individuals with total hip bone mineral density
(BMD) and 6,838 individuals with lumbar spine BMD and SNP
data were available for analysis. All participants gave informed
consent and the study was approved by the Data Protection
Commission of Iceland (DPC) and the National Bioethics
Committee of Iceland.
Clinical data
For each CoLaus participant a venous blood sample was
collected under fasting conditions. Measurements were conducted
using a Modular P apparatus (Roche Diagnostics, Switzerland).
Total serum calcium was measured by O-cresolphtalein (2.1% –
1.5% maximum inter and intra-batch CVs); albumin was
Table 2. Characteristics of participants, by study.
CoLaus
LOLIPOP
European Whites
LOLIPOP Indian
Asians InCHIANTI BLSA deCODE
Sample size 5404 1601 3947 1196 717 4126
Gender (males/females) 2542/2862 1397/204 3832/115 533/663 390/327 1313/2813
Age
(years)*
53.43
(34.9,75.4)
54.5
(22.6,75.0)
50.7
(35.0,74.9)
68.22
(21,102)
70.4
(22,98)
60.1
(7,103)
Pre/Post menopause 1210/1652 100/104 56/59 79/584 38/289 872/1836 (105 with pre
and post measurements)
Serum calcium
(mmol/L)*
2.29
(0.094)
2.41
(0.12)
2.37
(0.11)
2.36
(0.10)
2.31
(0.11)
2.38
(0.14)
Corrected serum
Calcium (mmol/L)*
2.18
(0.09)
2.31
(0.09)
2.29
(0.09)
2.30
(0.09)
2.30
(0.1)
2.31
(0.14)
Serum albumin
[g/L]*
44.2
(2.5)
43.7
(2.9)
43.4
(2.9)
42.3
(3.1)
40.4
(3.5)
42.9
(3.9)
Characteristics are shown for CoLaus, LOLIPOP European, LOLIPOP Indian Asian, InCHIANTI, BLSA and deCODE. Corrected serum calcium, designed to estimate the
amount of biologically active serum calcium, is defined as Ca_corrected = total serum calcium [mmol/L] + (40 - albumin [g/L])/40.
*Values represent mean (range) or mean (sd).
doi:10.1371/journal.pgen.1001035.t002
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measured by bromocresol green (2.5% – 0.4%). To further
characterize the identified genetic variants, we analyzed the
association with several outcomes postulated to be correlated with
serum calcium. Within the CoLaus study, we have questionnaire
responses to queries about personal histories of osteoporosis,
osteoarthritis, myocardial infarction and stroke in addition to
clinical data determining hypertension status, defined as previ-
ously described [17]. The assessment of LOLIPOP study
participants was carried out by a trained research nurse, during
a 45 minute appointment according to a standardized protocol
and with regular QC audits. An interviewer-administered
questionnaire was used to collect data on medical history, family
history, current prescribed medication, and cardiovascular risk
factors. Physical assessment included anthropometric measure-
ments (height, weight, waist, hip) and blood pressure. Blood was
collected after an 8 hour fast for biochemical analysis, including
glucose, insulin, total and HDL cholesterol and triglycerides, and
whole blood was taken for DNA extraction [59]. InCHIANTI
serum albumin concentrations were determined as percentage of
total protein using agarose electrophoretic technique (Hydragel
Protein (E) 15/30, Sebia, Issy-les-Moulineaux, France). Serum
calcium was measured using calorimetric assay (Roch Diagnostic,
GmbH, Mannheim, Germany) by a Roche-Hitachi autoanalyzer
(The intra-assay CV and 0.9% and the inter-assay CV was 1.5%).
Measures of bone density, bone dimensions and osteoporosis
diagnosis were assessed by peripheral quantitative computed
tomography (pQCT) using the XCT 2000 device (Stratec
Medizintechnik, Pforzheim, Germany) [62]. BLSA albumin
concentrations were measured by a calorimetric assay using
bromocresol green (Ortho-Clinical Diagnostics). Calcium
concentrations were measured by a calorimetric assay (Vitros
5,1,FS).
Genome-wide genotyping and imputation
CoLaus participants were genotyped using Affymetrix Hu-
man Mapping 500 K Array. For the genome-wide association
stage, genotyping in LOLIPOP participants was carried out
using the Illumina 317 K mapping array, Affymetrix Human
Mapping 500 K array, and Perlegen, 284 K platforms (Table
S1). Participants of the InCHIANTI and BLSA studies were
genotyped using Illumina Infinium HumanHap 550 K SNP
arrays were used for genotyping [21]. Imputation of allele
dosage of SNPs was performed using either MACH [63] or
IMPUTE [64] with parameters and quality control filters as
described in Table S1. All European cohorts imputed SNPs
typed in the HapMap CEU population; LOLIPOP Indian Asian
cohort imputed SNPs using mixed HapMap populations, given
that this showed greater concordance with real genotypes
compared with use of any one HapMap population. SNPs were
excluded if cohort-specific imputation quality as assessed by
r2.hat (MACH) or .info (IMPUTE) metrics were ,0.30. In
total, 2,557,252 genotyped or imputed SNPs had data from one
or more cohorts and were analyzed. Genotypes in deCODE
were measured using either humanHap300, humanHap300-duo
or humanCNV370.
Statistical analysis
Individual genome-wide association analysis. Biologically
active serum calcium is estimated by the correction, Ca_corrected
= total serum calcium [mmol/L] + (40 - albumin [g/L])/40. Indi-
viduals with values,1.9 or.3 were removed as these were extreme
outliers. Linear-regression analyses were carried out using an
additive genetic model on log10-transformed corrected calcium
levels adjusted for age and pseudosex (a factor variable with three
values: males, pre-menopausal females and post-menopausal
females). BLSA also included the first two and LOLIPOP
included the first four ancestry principal components in the
regression, respectively. Regression analyses were performed with
QUICKTEST [65] (CoLaus), MACH2qtl (LOLIPOP) [63] or
MERLIN [66] (InCHIANTI, BLSA).
Meta-analysis. The results from all cohorts were combined
into a fixed-effects meta-analysis using inverse variance
weighting. Tests for heterogeneity were assessed using
Cochran’s Q statistic and the log of the related H statistic [67]
after grouping LOLIPOP subsets into European and Indian
subsets. For rs1801725 and rs1042636 the p-values were
(0.07657, 0.1432) and (0.3450, 0.8876), respectively, indicating
Figure 1. Genome-wide association results. Manhattan plots
showing significance of association of all SNPs in the meta-analysis for
(A) combined European and Indian Asian cohorts, (B) European cohorts
only and (C) Indian Asian cohorts only. SNPs are plotted on the x-axis
according to their position on each chromosome against association
with serum calcium concentrations on the y-axis (shown as 2log10 p-
values).
doi:10.1371/journal.pgen.1001035.g001
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limited between-study variability. The analysis was implemented
in R and run on a quad-core Linux machine. SNPs were reported
provided they had effect size estimates in at least 2 of the 5
European cohorts, in at least 2 of the 3 Indian Asian cohorts, or
in at least 3 of the 8 total cohorts. For the overall meta-analysis,
residual inflation of the test statistic was corrected using genomic
control [68]. The inflation factor was 1.0207 for the all combined
cohorts, 1.0068 for European cohorts and 1.0286 for Indian
Asian cohorts. Where reported, individual study p-values are
corrected for inflation using genomic control methods for
genotyped and imputed SNPs combined (inflation factors for
individual studies were 1.0139 (CoLaus), 0.9891 (LOLIPOP
EWA), 0.9994 (LOLIPOP EWP), 0.9967 (LOLIPOP IAA),
1.0131 (LOLIPOP IAI), 0.9985 (LOLIPOP IAP), 0.9842
(InCHIANTI), 1.0019 (BLSA)). The regional association plot
(Figure 3) was created modifying a publically available R script
[69]. The map of fine-scale recombination rates was downloaded
from the HapMap website http://www.hapmap.org/downloads/
recombination/ using Phase II HapMap data (release 21).
Quantile-quantile plots of the association results are shown in
Figure S1A, S1B, S1C, study-specific quantile-quantile plots are
shown in Figure S2. Associations below p= 561028 were
Figure 2. Comparison of rs1801725 significance across cohorts. The effect size and 95% confidence intervals of the serum calcium
increasing T allele of SNP rs1801725 are shown separately for each cohort (CoLaus, LOLIPOP_EWA, LOLIPOP_EWP, LOLIPOP_IAA, LOLIPOP_IAI,
LOLIPOP_IAP, BLSA, InCHIANTI) and for the replication cohort deCODE. European cohorts are shown in blue and Indian Asian cohorts are drawn
in green. The size of the box is proportional to the precision 1/se2 and the meta-analysis estimate and 95% confidence interval across all cohorts
is given by a diamond.
doi:10.1371/journal.pgen.1001035.g002
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considered genome-wide significant, which corresponds to a
Bonferroni correction for the estimated one million independent
common variant tests in the human genome of European
individuals [70]. The analysis of osteoporosis status in CoLaus
and InCHIANTI was performed using logistic regression
including age and pseudosex as covariates in QUICKTEST
[65]. Linkage disequilibrium was estimated from HapMap CEU
(2007-01, build 35 non-redundant) genotypes. LD r2 statistics
were estimated for SNPs within 500 kb using Haploview [71].
Association of rs1801725 with calcium-related out-
comes. For each related trait (coronary heart disease,
hypertension, kidney stones, myocardial infarction, osteoarthritis,
osteoporosis and stroke) we performed a fixed-effects meta-analysis
of the logistic regression coefficients. We applied the bonferroni
correction to adjust for multiple testing. We performed Wald-
based power calculations using a type I error of 0.05/7 and meta-
analysis coefficient estimates and standard errors to estimate the
sample size for each trait giving power 0.80.
Figure 3. Regional association plot of the CASR locus. Plots show genomic position on the x-axis and 2log10 p-values on the y-axis for
SNPs in the CASR locus on chromosome 3. The sentinel hit is shown as a red square. Patterns of linkage disequilibrium between the sentinel SNP
and all other SNPs are color-coded. Red circles indicate high correlation (r2.0.8), green circles indicate moderate correlation (r2.0.5), blue
circles indicate low correlation (r2.0.2) and black circles indicate no correlation (r2,0.2). The fine-scale recombination rates from [72–73] are
plotted in light blue.
doi:10.1371/journal.pgen.1001035.g003
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Supporting Information
Figure S1 Quantile-Quantile plots of genome-wide association
results. Observed -log10 p-values on the y-axis are plotted against
theoretical -log10 p-values on the x-axis resulting from each meta-
analysis. Results are color-coded by chromosome. The top results
largely derive from the CASR locus on chromosome 3. Results are
shown separately for (A) all cohorts, (B) European cohorts and (C)
Indian Asian cohorts.
Found at: doi:10.1371/journal.pgen.1001035.s001 (6.48 MB TIF)
Figure S2 Study-specific quantile-quantile plots. Shown are
observed -log10 p-values plotted against expected -log10 p-values
resulting from each single study after applying genomic control
correction. The study-specific l-values were l=1.0139 (CoLaus),
l=0.9891 (LOLIPOP_EWA), l=0.9994 (LOLIPOP_EWP),
l=0.9967 (LOLIPOP_IAA), l=1.0131 (LOLIPOP_IAI),
l=0.9985 (LOLIPOP_IAP), l=0.9842 (InCHIANTI),
Table 3. Significance of top SNPs.
Combined European and Indian Asian Cohorts
db SNP Chr
Position
(Build 35)
Coded
Allele
Non-
Coded
Allele
Frequency
Coded Allele Beta Se
Lower 95%
CI
Upper 95%
CI P-value R2
rs1801725 3 123486447 T G 17.75 3.61E-03 2.81E-04 3.06E-03 4.16E-03 6.29E-37 0.0126
rs17120351 8 14731368 T C 96.24 4.03E-03 7.67E-04 2.52E-03 5.53E-03 2.06E-07 0.0021
rs7448017 5 117800594 T G 17.83 -1.73E-03 3.57E-04 -2.43E-03 -1.03E-03 1.65E-06 0.0018
rs742393 1 25271187 G A 78.86 2.11E-03 4.44E-04 1.24E-03 2.98E-03 2.41E-06 0.0018
rs16827695 1 40956147 G A 94.52 3.46E-03 7.41E-04 2.01E-03 4.92E-03 3.74E-06 0.0017
rs1550532 2 234046848 G C 74.24 -1.15E-03 2.48E-04 -1.64E-03 -6.66E-04 4.28E-06 0.0017
rs261503 13 81305121 G A 91.35 2.45E-03 5.29E-04 1.41E-03 3.49E-03 4.60E-06 0.0017
rs10119 19 50098513 G A 73.82 -1.63E-03 3.53E-04 -2.33E-03 -9.41E-04 4.76E-06 0.0017
rs17666460 6 149298132 G A 11.16 1.93E-03 4.18E-04 1.11E-03 2.75E-03 4.81E-06 0.0017
rs16902486 8 129024247 G C 4.26 -2.66E-03 5.75E-04 -3.78E-03 -1.53E-03 4.83E-06 0.0017
rs17005914 2 70721826 T C 21.4 -1.47E-03 3.24E-04 -2.11E-03 -8.38E-04 6.76E-06 0.0016
rs10455097 6 74550153 C A 47.75 -9.58E-04 2.15E-04 -1.38E-03 -5.37E-04 9.94E-06 0.0015
European Cohorts
db SNP Chr
Position
(Build 35)
Coded
Allele
Non-
Coded
Allele
Frequency
Coded
Allele Beta Se
Lower 95%
CI
Upper 95%
CI P-value R2
rs1801725 3 123486447 T G 16.76 3.11E-03 3.55E-04 2.41E-03 3.80E-03 2.58E-18 0.0085
rs17120351 8 14731368 T C 96.24 4.03E-03 7.67E-04 2.52E-03 5.53E-03 1.69E-07 0.0031
rs7448017 5 117800594 T G 17.83 -1.73E-03 3.57E-04 -2.43E-03 -1.03E-03 1.40E-06 0.0026
rs16827695 1 40956147 G A 94.45 3.46E-03 7.41E-04 2.01E-03 4.92E-03 3.20E-06 0.0024
rs261503 13 81305121 G A 91.35 2.45E-03 5.29E-04 1.41E-03 3.49E-03 3.95E-06 0.0024
rs16902486 8 129024247 G C 4.7 -2.92E-03 6.30E-04 -4.15E-03 -1.68E-03 4.04E-06 0.0024
rs17666460 6 149298132 G A 11.16 1.93E-03 4.18E-04 1.11E-03 2.75E-03 4.13E-06 0.0024
rs12325114 16 72861392 T C 76.14 -1.40E-03 3.05E-04 -2.00E-03 -8.01E-04 4.86E-06 0.0024
rs6427310 1 150628843 T C 16.29 -1.65E-03 3.60E-04 -2.35E-03 -9.41E-04 5.09E-06 0.0023
rs17005914 2 70721826 T C 21.4 -1.47E-03 3.24E-04 -2.11E-03 -8.38E-04 5.83E-06 0.0023
rs12416668 10 83645028 T C 94.94 -2.77E-03 6.18E-04 -3.98E-03 -1.56E-03 7.60E-06 0.0023
rs6111021 20 16221853 C A 41.75 1.20E-03 2.67E-04 6.71E-04 1.72E-03 8.36E-06 0.002
Indian Asian Cohorts
db SNP Chr
Position
(Build 35)
Coded
Allele
Non-
Coded
Allele
Frequency
Coded AlleleBeta Se
Lower 95%
CI
Upper 95%
CI P-value R2
rs17251221 3 123475937 G A 19.24 4.72E-03 4.86E-04 3.76E-03 5.67E-03 1.07E-21 0.0233
rs13203335 6 166194438 T C 28.04 -2.91E-03 5.70E-04 -4.03E-03 -1.79E-03 4.70E-07 0.0066
rs4695355 4 48030638 G A 40.26 1.72E-03 3.75E-04 9.89E-04 2.46E-03 5.70E-06 0.0053
rs10846917 12 124568003 T C 59.69 1.74E-03 3.78E-04 9.98E-04 2.48E-03 5.79E-06 0.0053
We report SNPs with p-values ,1E-05 filtered by distinct regions, determined by merging SNPs within 1 Mb of each other. Results are given for different cohort subsets
of combined European and Indian Asian cohorts, European cohorts, and Indian Asian cohorts. The Beta and SE values represent the effect of the coded allele on log10
corrected serum calcium levels; R2 represents the fraction of variation explained by the SNP.
doi:10.1371/journal.pgen.1001035.t003
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l=1.0019 (BLSA). For the combined European and Indian Asian,
European only and Indian Asian only meta-analyses the inflation
factors were 1.0207, 1.0068, and 1.0286, respectively.
Found at: doi:10.1371/journal.pgen.1001035.s002 (4.36 MB TIF)
Figure S3 Comparison of significance across cohorts. The effect
size and 95% confidence intervals of SNPs which do not reach
genome-wide significance in the combined European and Indian
Asian meta-analysis are shown separately for each cohort (CoLaus,
LOLIPOP_EWA, LOLIPOP_EWP, LOLIPOP_IAA, LOLIPO-
P_IAI, LOLIPOP_IAP, BLSA, InCHIANTI). European cohorts
are drawn in blue and Indian Asian cohorts are drawn in green.
The size of the box is proportional to the precision 1/se2 and the
meta-analysis estimate and 95% confidence interval across all
cohorts is given by a diamond.
Found at: doi:10.1371/journal.pgen.1001035.s003 (0.38 MB
TIF)
Figure S4 Candidate gene QQ-plots. For 18611 SNPs mapping
to candidate genes (excluding CASR), we compare observed -log10
p-values to the mean quantiles of the uniform distribution. As a
comparison, we randomly choose a set of genes from which we
select the same number of SNPs. From 1,000 random draws we
calculate the 95th percentile of -log10 p-values (in blue). Results are
shown separately for all cohorts, European only and Indian Asian
only (A–C). CoLaus permuted phenotype results comparing
observed p-values to the 95th percentile of -log10 p-values from
100 permutations are shown in (D).
Found at: doi:10.1371/journal.pgen.1001035.s004 (0.41 MB TIF)
Table S1 Genotyping, imputation, and analysis procedures by
study. The genotyping platforms, quality control (QC) filters applied
before imputation, imputation software, number of SNPs, and
genotype-phenotype association software are shown for each study.
Found at: doi:10.1371/journal.pgen.1001035.s005 (0.05 MB
DOC)
Table S2 Complete list of genome-wide significant SNPs. Below
is the list of all SNPs that exceeded the threshold of genome-wide
significance (p,5610e-8). Position is given for NCBI Build 35.
Meta-analysis is performed by inverse variance weighted fixed
effect regression. The coded allele is the allele to which the beta
(effect) estimate refers. Results are shown separately for (A)
European and Indian Asian cohorts, (B) European cohorts only,
and (C) Indian Asian cohorts only.
Found at: doi:10.1371/journal.pgen.1001035.s006 (0.24 MB
DOC)
Table S3 Significance of top SNPs by cohort. Shown are study-
specific results of the SNPs with genomic control (GC) p-values
,1E-05 filtered by distinct regions, determined by merging SNPs
within 1 Mb of each other. Results are shown separately for (A)
European and Indian Asian cohorts, (B) European cohorts, and
(C) Indian Asian cohorts.
Found at: doi:10.1371/journal.pgen.1001035.s007 (0.08 MB
DOC)
Table S4 Number of cases and controls for calcium-related
outcomes. For several related phenotypes, we test the association
of rs1801725 with these binary responses. Shown here are the
number of cases and controls for each phenotype in each cohort
and the total across cohorts.
Found at: doi:10.1371/journal.pgen.1001035.s008 (0.04 MB
DOC)
Table S5 Logistic regression of clinical phenotypes on rs1801725.
We report the effect size and standard error of the rs1801725 T allele
from logistic regressions of each clinical phenotype.
Found at: doi:10.1371/journal.pgen.1001035.s009 (0.04 MB
DOC)
Table S6 Studies of CASR mutations and serum calcium. A
survey of previous studies which investigate the relationship
between CASR mutations and levels of serum calcium.
Found at: doi:10.1371/journal.pgen.1001035.s010 (0.05 MB
DOC)
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